In addition, PD-L1 was key in mediating IFNγ regulation of glucose and glutamine metabolism, although not through transcriptional regulation of metabolic enzymes (Figures 3, 4) and unlike a report of PD-L1 regulating HK2 in non-small cell lung cancer (25). The gene discussed is IFNG; the disease is non-small cell lung carcinoma.